14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SANN.SW
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Santhera Pharmaceuticals Holding AG stock after losing 0.96%
(Updated on May 17, 2024)

Sell candidate since May 16, 2024 Loss -0.96% PDF

The Santhera Pharmaceuticals Holding AG stock price fell by -0.96% on the last day (Friday, 17th May 2024) from 9.34 Fr to 9.25 Fr. During the last trading day the stock fluctuated 1.73% from a day low at 9.24 Fr to a day high of 9.40 Fr. The price has fallen in 6 of the last 10 days and is down by -1.28% for this period. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 17 thousand shares were bought and sold for approximately 155.09 Fr thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.27% during the next 3 months and, with a 90% probability hold a price between 7.78 Fr and 8.83 Fr at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SANN.SW Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, May 06, 2024, and so far it has risen 2.10%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Santhera Pharmaceuticals Holding AG stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 9.26 Fr and 9.42 Fr. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Santhera Pharmaceuticals Holding AG gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Santhera Pharmaceuticals Holding AG stock

Santhera Pharmaceuticals Holding AG finds support from accumulated volume at 9.11 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved 0.160 Fr (1.73%) between high and low. For the last week, the stock has had daily average volatility of 2.78%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SANN.SW) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Santhera Pharmaceuticals Holding AG to open at 9.30 Fr, and during the day (based on 14 day Average True Range), to move between 8.90 Fr and 9.60 Fr, which gives a possible trading interval of +/-0.355 Fr (+/-3.83%) up or down from last closing price. If Santhera Pharmaceuticals Holding AG takes out the full calculated possible swing range there will be an estimated 7.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 9.11 Fr (1.51%) than the resistance at 9.50 Fr (2.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Santhera Pharmaceuticals Holding AG stock A Buy?

Santhera Pharmaceuticals Holding AG holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.799 Sell Candidate Unchanged

Predicted Opening Price for Santhera Pharmaceuticals Holding AG of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
9.30 Fr ( 0.505%) 9.25 Fr

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SANN.SW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.46 2.23 %
R2 9.40 1.57 %
R1 9.36 1.17 %
Current price: 9.25
Support S1 9.24 -0.156 %
S2 9.20 -0.564 %
S3 9.14 -1.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.36 22.81 %
R2 10.50 13.51 %
R1 9.50 2.70 %
Current price 9.25
Support S1 9.11 -1.51%
S2 9.10 -1.62%
S3 9.06 -2.05%

FAQ

What is the symbol for Santhera Pharmaceuticals Holding AG Stock and on which exchange is it traded?
The symbol for Santhera Pharmaceuticals Holding AG is SANN.SW and it is traded on the SIX (SIX Swiss Exchange).

Should I buy or sell Santhera Pharmaceuticals Holding AG Stock?
Santhera Pharmaceuticals Holding AG holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Santhera Pharmaceuticals Holding AG Stock?
Santhera Pharmaceuticals Holding AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Santhera Pharmaceuticals Holding AG Stock.

What's the current price of Santhera Pharmaceuticals Holding AG Stock?
As of the end of day on the May 17, 2024, the price of an Santhera Pharmaceuticals Holding AG (SANN.SW) share was 9.25 Fr.

What is the 52-week high and low for Santhera Pharmaceuticals Holding AG Stock?
The 52-week high for Santhera Pharmaceuticals Holding AG Stock is 14.62 Fr and the 52-week low is 0.611 Fr.

What is the market capitalization of Santhera Pharmaceuticals Holding AG Stock?
As of the May 17, 2024, the market capitalization of Santhera Pharmaceuticals Holding AG is 81.503M.

When is the next earnings date for Santhera Pharmaceuticals Holding AG?
The upcoming earnings date for Santhera Pharmaceuticals Holding AG is Sep 05, 2024.
Click to get the best stock tips daily for free!

About Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodeles... SANN.SW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT